How Sharps Technology is institutionalizing its Solana treasury strategy with BitGo custody and staking services
Discover how Sharps Technology’s partnership with BitGo is reshaping its Solana treasury strategy and what it signals for public company crypto governance.
Could HEICO’s Ethos A&C acquisition signal a new M&A phase in energy–aviation convergence?
HEICO expands into energy–aviation turbine repair with Ethos A&C acquisition. Find out what this strategic move signals for future M&A and market shifts.
How P10, Inc.’s acquisition of Stellus Capital Management reshapes scale economics in U.S. lower-middle market credit (NYSE: PX)
Discover how P10, Inc.’s $250M Stellus Capital acquisition reshapes its private credit strategy and what it means for investors and markets. Read more.
What Silver Bullet’s Columbia–Gold Queen acquisitions signal about junior mining discipline in 2026
Silver Bullet Mines acquires two Arizona mines near its Globe mill in a no-dilution deal. Find out how this move could redefine its production strategy.
Why this $675M acquisition could redefine Kodiak’s future beyond oilfield compression
Kodiak Gas Services is acquiring DPS for $675M to scale into data center and modular power infrastructure. Discover how this reshapes its strategic roadmap.
How EMA’s support for EURneffy 1 mg could disrupt Europe’s pediatric epinephrine market
EMA backs EURneffy 1 mg for pediatric anaphylaxis. Find out how ARS Pharmaceuticals and ALK-Abelló could reshape Europe’s allergy care landscape.
How FDA scrutiny of packaging and administration stalled Anaphylm despite clinical comparability to auto-injectable epinephrine
FDA scrutiny stalled Anaphylm despite strong clinical data. Find out what this means for epinephrine innovation, regulatory risk, and investor expectations.
Will Polyrizon’s $5.8m move into private aviation reshape its biotech-focused capital strategy? (NASDAQ: PLRZ)
Polyrizon plans to buy 51% of Arrow Aviation in a $5.8M deal. Find out how this biotech-to-aviation pivot could reshape its capital strategy.
Will Texas Instruments’ $7.5bn Silicon Labs deal reshape the embedded wireless landscape? (Nasdaq: TXN, SLAB)
Texas Instruments is acquiring Silicon Labs for $7.5B to scale its embedded wireless portfolio. Find out how this deal could reshape the connected device landscape.
Can prescription discounts improve uptake of FDA-approved malaria prevention drugs in 2026?
Can tafenoquine’s GoodRx discount model reset malaria drug access strategy? Read how retail-driven pricing may reshape travel health in 2026.